Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Big Data: What Every Rheumatologist Should Know
-
- Six Top Stories From the EULAR Annual Congress
- EMA to Review Marketing Authorization Application of Biosimilar to Candidate to Humira
- Proposed Biosimilars to Humira, Remicade Accepted for Review by EMA
- Subcutaneous Abatacept Now Available for Patients With JIA
- Big Data in Rheumatology: Is it a Cautionary Note? Leonard H. Calabrese, DO
- AAHKS, ACR Release Guidelines for Management of Antirheumatic Drugs for Patients Who Undergo TKA, THA
- ACR Issues Statement After FDA Releases Guidance on Biosimilar Interchangeability
- Adalimumab Biosimilar Showed Similar Safety, Efficacy as Reference Product in Patients With RA
-
- Both HA and PRP Linked With Significantly Improved Pain Relief in Patients With Knee OA
- Greater Fish Consumption Linked to Lower RA Disease Activity
- Nail Findings Distinguish Between Psoriasis, Psoriatic Arthritis
- State Medical Licensing Board Questions May Discourage Physicians From Addressing Their Mental Health
- Study: Fibromyalgia May Mask Axial Spondyloarthritis
- Early Intervention May Reduce Onset of RA
- Long-term Hydroxychloroquine Therapy May Reduce Cardiovascular Events in SLE
- Nailfold Videocapillaroscopy May Aid in Early Diagnosis of Systemic Sclerosis
-
- Romosozumab Reduced Vertebral Fracture Risk in Older Women With Osteoporosis
- Study Finds FKB327 Non-inferior to Adalimumab Regarding Pharmacokinetics, Safety
- New Generation of Rheumatologists Needed to Meet Future Demand
- Supreme Court Ruling Accelerates Availability of Biosimilars